Suppr超能文献

BET 结构域共调节因子与肥胖、炎症和癌症。

BET domain co-regulators in obesity, inflammation and cancer.

机构信息

Cancer Research Center, Nutrition Obesity Research Center, Departments of Medicine and Pharmacology, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA.

出版信息

Nat Rev Cancer. 2012 Jun 22;12(7):465-77. doi: 10.1038/nrc3256.

Abstract

The bromodomain is a highly conserved motif of 110 amino acids that is bundled into four anti-parallel α-helices and found in proteins that interact with chromatin, such as transcription factors, histone acetylases and nucleosome remodelling complexes. Bromodomain proteins are chromatin 'readers'; they recruit chromatin-regulating enzymes, including 'writers' and 'erasers' of histone modification, to target promoters and to regulate gene expression. Conventional wisdom held that complexes involved in chromatin dynamics are not 'druggable' targets. However, small molecules that inhibit bromodomain and extraterminal (BET) proteins have been described. We examine these developments and discuss the implications for small molecule epigenetic targeting of chromatin networks in cancer.

摘要

溴结构域是一个高度保守的 110 个氨基酸的基序,折叠成四个反平行的α-螺旋,存在于与染色质相互作用的蛋白质中,如转录因子、组蛋白乙酰转移酶和核小体重塑复合物。溴结构域蛋白是染色质的“读取器”;它们招募染色质调节酶,包括组蛋白修饰的“书写器”和“橡皮擦”,以靶向启动子并调节基因表达。传统观点认为,参与染色质动力学的复合物不是“可成药”的靶标。然而,已经描述了抑制溴结构域和末端(BET)蛋白的小分子。我们检查了这些进展,并讨论了它们对癌症中小分子表观遗传靶向染色质网络的影响。

相似文献

2
Bromodomain inhibitors and cancer therapy: From structures to applications.溴结构域抑制剂与癌症治疗:从结构到应用
Epigenetics. 2017 May 4;12(5):323-339. doi: 10.1080/15592294.2016.1265710. Epub 2016 Dec 2.
5
A mechanism for epigenetic control of DNA replication.一种用于 DNA 复制的表观遗传控制机制。
Genes Dev. 2018 Feb 1;32(3-4):224-229. doi: 10.1101/gad.306464.117. Epub 2018 Feb 26.
9
Emerging roles of and therapeutic strategies targeting BRD4 in cancer.BRD4 在癌症中的新兴作用和治疗靶点。
Cell Immunol. 2019 Mar;337:48-53. doi: 10.1016/j.cellimm.2019.02.001. Epub 2019 Feb 4.

引用本文的文献

7
Advancements in PROTAC-based therapies for neurodegenerative diseases.基于PROTAC的神经退行性疾病治疗方法的进展。
Future Med Chem. 2025 Mar;17(5):591-605. doi: 10.1080/17568919.2025.2463310. Epub 2025 Feb 11.

本文引用的文献

6
Pathogenesis of NUT midline carcinoma.NUT 中线癌的发病机制。
Annu Rev Pathol. 2012;7:247-65. doi: 10.1146/annurev-pathol-011811-132438. Epub 2011 Oct 17.
9
Targeting MYC dependence in cancer by inhibiting BET bromodomains.通过抑制 BET 溴结构域靶向癌症中的 MYC 依赖性。
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16669-74. doi: 10.1073/pnas.1108190108. Epub 2011 Sep 26.
10
Bromodomains as therapeutic targets.溴结构域作为治疗靶点。
Expert Rev Mol Med. 2011 Sep 13;13:e29. doi: 10.1017/S1462399411001992.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验